Paolo Tarantino, Visiting Professor at McGill University Health Centre, shared on X:
”Glad to see our article on the RW activity of post-T-DXd regimens among the most read on JNCI!
It addressed a simple question: what works best among patients with MBC and prior T-DXd? (Unsurprising) answer: switching mechanism of action of the chemo.”
Title: Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
Authors: Paolo Tarantino, Do Lee, Julia Foldi, Pamela R. Soulos, Cary P. Gross, Tess O’Meara, Thomas Grinda, Stefania Morganti, Adrienne G. Waks, Eric P. Winer, Nancy U. Lin, Ian E. Krop, Sara M. Tolaney, Sarah Sammons, Maryam Lustberg
Other articles about cancer types on OncoDaily.